ER represents a critical BrCa characteristic, with the activation and the underlying regulatory machinery of various growth-promoting pathways to be considered as most critical for the molecular characterization and prognosis of BrCa (e.g., the ErbB signaling pathway). The gene discussed is EGFR; the disease is invasive breast carcinoma.